The guidelines for clinical data in Japan, as outlined by the PMDA, require robust evidence of a medical device’s safety & efficacy. Clinical data should include results from well-designed clinical trials, post-market surveillance, & relevant scientific literature. Compliance with Good Clinical Practice (GCP) standards is mandatory, ensuring ethical conduct & reliable data for regulatory review.
